Therapeutic Potential of Allicin in Multi-System Inflammatory Diseases
Jieyou Zhao, Jiawen Zhao, Zhaoyang Li, Nana Cheng, Chenhao Feng, Yunjia Song, Xutao Sun · 2026
Read Therapeutic Potential of Allicin in Multi-System Inflammatory Diseases by Jieyou Zhao, Jiawen Zhao, Zhaoyang Li, Nana Cheng, Chenhao Feng, Yunjia Song, Xutao Sun (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13605768.txt.
Description
Jieyou Zhao and co-authors review the promise of allicin, the active compound in garlic, against inflammatory disease, in a 2026 paper. Inflammation drives damage in many long-term illnesses. Standard anti-inflammatory drugs can lose effect or cause harm over time. Safer options remain in demand.
Allicin is the main bioactive sulfur compound released when garlic is crushed. Lab and animal studies link it to calmer immune responses. It appears to curb inflammatory cell activation and cut oxidative stress. Protective effects show up across models of disease in several organ systems. The review weighs that evidence and its limits. It maps where clinical trials should go next. Readers get a sober view of a popular natural remedy.
Catalog record
| CREATOR | Jieyou Zhao, Jiawen Zhao, Zhaoyang Li, Nana Cheng, Chenhao Feng, Yunjia Song, Xutao Sun |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 80 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |